To view this email as a web page, click here.

 
FDA approves treatment for underarm sweating
In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.
ADVERTISEMENT
 
Analysis shows nurses are overworked
Hawaii has the most overworked RN workforce, according to a report by Medicare Health Plann issued in June.
ADVERTISEMENT
 
EC moves forward with new PsA treatment
In June, the European Commission approved tofacitinib citrate (Xeljanz/Pfizer) 5 mg twice daily in combination with methotrexate for adults with psoriatic arthritis. Learn about the parameters here.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
No matter the location, patients still want to look great
It may be easy to dismiss body contouring services as a luxury that only makes sense in affluent or cosmopolitan settings. Find out how one rural-based dermatologist has shattered this myth. Learn more in this podcast.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.